Our research, conducted in serum-deprived conditions, provides the groundwork for an experimental model to test the effect of therapeutic candidates on BAFF-mediated autoimmune disease-like states with ROS production and MMP collapse. This evidence concerns the gene TNFSF13B and autoimmune disease.